China NMPA Drug Inspection - Weifang Municipal Institute of Dermatology and Venereology - Jing Antipruritic Granules
China NMPA drug inspection for Weifang Municipal Institute of Dermatology and Venereology published November 18, 2019. Drug: Jing Antipruritic Granules. An announcement from the Shandong Provincial Food and Drug Administration, dated November 10, 2017, revealed that severa
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Weifang Municipal Institute of Dermatology and Venereology published November 18, 2019. Drug: Jing Antipruritic Granules. An announcement from the Shandong Provincial Food and Drug Administration, dated November 10, 2017, revealed that severa
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox